Observational studyScientific reports2026
A prospective observational study evaluating drug-related problems and their impact on patient-related outcomes in hospitalized epileptic patients.
Observational study in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This observational study assessed drug-related problems (DRPs) and their effect on patient-related outcomes (PROs) in 120 hospitalized epileptic patients. Antiseizure medications (ASM) administered included levetiracetam (98%), valproic acid (31%), carbamazepine (18.3%), and phenytoin (16%). Antibiotics such as ceftriaxone (64%), vancomycin (30%), meropenem (31%), and piperacillin-tazobactam (53%) were primarily used to treat hospital-acquired infections (HAIs) and status epilepticus. Klebsiella pneumoniae (17%) and Streptococcus pneumoniae (16%) were the main culprits causing HAIs. Ventilator-associated pneumonia (VAP), hospital-acquired pneumonia (HAP), catheter-associated urinary tract infections (CAUTI), Central line-associated bloodstream infections (CLABSI), fever, and sinusitis are the HAIs faced by 45% of the patients. PCNE classification V.9.1 was used for the evaluation of DRPs in hospitalized epileptic patients. DRPs are found to be involved in causing many serious problems in hospitalized epileptic patients; they not only cause drug-drug interactions (DDIs) but also affect the patient's quality of life (QOL), morbidity, and mortality rate. This study was incredibly insightful in evaluating DRPs and numerous clinical scenarios that affect PROs. Irrational use of antibiotics and other narrow therapeutic drugs should be administered and prescribed carefully since they have an impact on patient QOL, extended hospital stay, expensive treatment, and mortality rates in developing low and middle-income countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.